Legend Biotech (NASDAQ: LEGN) reported Q2 EPS of ($0.05), $0.24 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $186.52 million versus the consensus estimate of $125.25 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.